These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 20815658)
1. Characterization of peptide fragments from lung elastin degradation in chronic obstructive pulmonary disease. He J; Turino GM; Lin YY Exp Lung Res; 2010 Nov; 36(9):548-57. PubMed ID: 20815658 [TBL] [Abstract][Full Text] [Related]
2. Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS/MS as biomarkers for elastin degradation. Ma S; Turino GM; Lin YY J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1893-8. PubMed ID: 21621489 [TBL] [Abstract][Full Text] [Related]
3. Mapping of macrophage elastase cleavage sites in insoluble human skin elastin. Taddese S; Weiss AS; Neubert RH; Schmelzer CE Matrix Biol; 2008 Jun; 27(5):420-8. PubMed ID: 18334288 [TBL] [Abstract][Full Text] [Related]
4. Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease. Turino GM; Ma S; Lin YY; Cantor JO; Luisetti M Am J Respir Crit Care Med; 2011 Sep; 184(6):637-41. PubMed ID: 21757624 [TBL] [Abstract][Full Text] [Related]
5. Study of human lung elastin degradation by different elastases using high-performance liquid chromatography/mass spectrometry. Barroso B; Abello N; Bischoff R Anal Biochem; 2006 Nov; 358(2):216-24. PubMed ID: 16962555 [TBL] [Abstract][Full Text] [Related]
6. Elastin degradation: an effective biomarker in COPD. Turino GM; Lin YY; He J; Cantor JO; Ma S COPD; 2012 Aug; 9(4):435-8. PubMed ID: 22734624 [No Abstract] [Full Text] [Related]
7. Impairment of neutrophil reactivity to elastin peptides in COPD. Dupont A; Dury S; Gafa V; Lebargy F; Deslée G; Guenounou M; Antonicelli F; Le Naour R Thorax; 2013 May; 68(5):421-8. PubMed ID: 23359459 [TBL] [Abstract][Full Text] [Related]
8. Human leukocyte elastase hydrolysis of peptides derived from human elastin exon 24. Lombard C; Arzel L; Bouchu D; Wallach J; Saulnier J Biochimie; 2006 Dec; 88(12):1915-21. PubMed ID: 16945464 [TBL] [Abstract][Full Text] [Related]
9. Lipid metabolite levels of prostaglandin D2 and eicosapentaenoic acid recovered from bronchoalveolar lavage fluid correlate with lung function of chronic obstructive pulmonary disease patients and controls. Csanky E; Rühl R; Scholtz B; Vasko A; Takacs L; Hempel WM Electrophoresis; 2009 Apr; 30(7):1228-34. PubMed ID: 19294692 [TBL] [Abstract][Full Text] [Related]
10. Desmosine as a biomarker of elastin degradation in COPD: current status and future directions. Luisetti M; Ma S; Iadarola P; Stone PJ; Viglio S; Casado B; Lin YY; Snider GL; Turino GM Eur Respir J; 2008 Nov; 32(5):1146-57. PubMed ID: 18978133 [TBL] [Abstract][Full Text] [Related]
11. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD. Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682 [TBL] [Abstract][Full Text] [Related]
12. [A turning point in the knowledge of the structure-function-activity relations of elastin]. Alix AJ J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705 [TBL] [Abstract][Full Text] [Related]
13. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function. Eickmeier O; Huebner M; Herrmann E; Zissler U; Rosewich M; Baer PC; Buhl R; Schmitt-Grohé S; Zielen S; Schubert R Cytokine; 2010 May; 50(2):152-7. PubMed ID: 20181491 [TBL] [Abstract][Full Text] [Related]
14. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation]. Xin XF; Zhao M; Li ZL; Song Y; Shi Y Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998 [TBL] [Abstract][Full Text] [Related]
15. Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification. Merkel D; Rist W; Seither P; Weith A; Lenter MC Proteomics; 2005 Jul; 5(11):2972-80. PubMed ID: 16075419 [TBL] [Abstract][Full Text] [Related]
16. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. Ohlmeier S; Vuolanto M; Toljamo T; Vuopala K; Salmenkivi K; Myllärniemi M; Kinnula VL J Proteome Res; 2008 Dec; 7(12):5125-32. PubMed ID: 19367700 [TBL] [Abstract][Full Text] [Related]
17. Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation. Dentener MA; Vernooy JH; Hendriks S; Wouters EF Thorax; 2005 Feb; 60(2):114-9. PubMed ID: 15681498 [TBL] [Abstract][Full Text] [Related]
18. Chromatographic studies of human lung elastin digestion products obtained by leucocyte elastase: comparison between newborn and adult soluble fragments. Smyrlaki M; Davril M; Hayem A Biomed Chromatogr; 1987; 2(2):57-61. PubMed ID: 3506835 [TBL] [Abstract][Full Text] [Related]
19. Determination of N epsilon-(carboxymethyl)lysine in exhaled breath condensate using isotope dilution liquid chromatography/electrospray ionization tandem mass spectrometry. Gonzalez-Reche LM; Kucharczyk A; Musiol AK; Kraus T Rapid Commun Mass Spectrom; 2006; 20(18):2747-52. PubMed ID: 16921564 [TBL] [Abstract][Full Text] [Related]
20. Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease. Vizza CD; Letizia C; Sciomer S; Naeije R; Della Rocca G; Di Roma A; Musarò S; Quattrucci S; Gaudio C; Battagliese A; Badagliacca R; D'Erasmo E; Fedele F Regul Pept; 2005 Jan; 124(1-3):187-93. PubMed ID: 15544858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]